SciFluour Secures $5M in Funding

SciFluour Life Sciences has secured $5M in funding from Allied Sciences, a private equity firm. SciFluour uses late-stage fluorination of drugs to, among other purposes, help penetrate the blood-brain barrier, a key obstacle in the delivery of drugs for neurodegenerative diseases such as ALS.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail